ACADIA Pharmaceuticals Inc (ACAD)
16.18
-0.09
(-0.55%)
USD |
NASDAQ |
Nov 21, 16:00
16.20
+0.02
(+0.09%)
Pre-Market: 20:00
ACADIA Pharmaceuticals Total Liabilities (Quarterly): 399.69M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 399.69M |
| June 30, 2024 | 397.40M |
| March 31, 2024 | 391.06M |
| December 31, 2023 | 317.20M |
| September 30, 2023 | 270.37M |
| June 30, 2023 | 246.98M |
| March 31, 2023 | 281.05M |
| December 31, 2022 | 187.40M |
| September 30, 2022 | 176.80M |
| June 30, 2022 | 177.92M |
| March 31, 2022 | 179.45M |
| December 31, 2021 | 159.23M |
| September 30, 2021 | 150.72M |
| June 30, 2021 | 159.59M |
| March 31, 2021 | 173.57M |
| December 31, 2020 | 155.61M |
| September 30, 2020 | 140.80M |
| June 30, 2020 | 96.64M |
| March 31, 2020 | 109.07M |
| December 31, 2019 | 84.05M |
| September 30, 2019 | 76.30M |
| June 30, 2019 | 71.97M |
| March 31, 2019 | 82.75M |
| December 31, 2018 | 61.12M |
| September 30, 2018 | 43.02M |
| Date | Value |
|---|---|
| June 30, 2018 | 50.24M |
| March 31, 2018 | 46.87M |
| December 31, 2017 | 49.22M |
| September 30, 2017 | 36.39M |
| June 30, 2017 | 41.18M |
| March 31, 2017 | 45.49M |
| December 31, 2016 | 42.74M |
| September 30, 2016 | 39.33M |
| June 30, 2016 | 29.22M |
| March 31, 2016 | 21.34M |
| December 31, 2015 | 22.13M |
| September 30, 2015 | 17.97M |
| June 30, 2015 | 19.72M |
| March 31, 2015 | 16.87M |
| December 31, 2014 | 15.97M |
| September 30, 2014 | 11.27M |
| June 30, 2014 | 9.357M |
| March 31, 2014 | 8.046M |
| December 31, 2013 | 6.987M |
| September 30, 2013 | 18.53M |
| June 30, 2013 | 25.43M |
| March 31, 2013 | 23.35M |
| December 31, 2012 | 23.61M |
| September 30, 2012 | 6.086M |
| June 30, 2012 | 9.166M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
84.05M
Minimum
Dec 2019
399.69M
Maximum
Sep 2024
212.73M
Average
177.36M
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 76.47B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 976.87M |
| Shareholders Equity (Quarterly) | 577.18M |
| Current Ratio | 2.292 |